Quick Answer
TriSalus Life Sciences, Inc. reported Gross Profit of $38.19 million for fiscal year 2025.
TriSalus Life Sciences, Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $38.19M | +50.8% |
| 2024 | $25.33M | +59.2% |
| 2023 | $15.91M | +56.9% |
| 2022 | $10.14M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $9.66M | +52.2% | +2.6% |
| June 30, 2025 | $9.41M | +45.9% | +22.7% |
| March 31, 2025 | $7.67M | +39.8% | +20.9% |
| September 30, 2024 | $6.34M | +37.8% | -1.7% |
| June 30, 2024 | $6.45M | +68.0% | +17.6% |
| March 31, 2024 | $5.49M | +136.3% | +19.2% |
| September 30, 2023 | $4.60M | +42.9% | +19.9% |
| June 30, 2023 | $3.84M | — | +65.4% |
- TriSalus Life Sciences, Inc. showed an increase of +50.8% in Gross Profit compared to the prior fiscal year.
- Over the 2022–2025 period, TriSalus Life Sciences, Inc.’s gross profit has grown by 276.6% (from $10.14 million to $38.19 million).
- The most recent figure is from TriSalus Life Sciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: